CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in LLY — ELI LILLY & Co
CIK 884546
SAN FRANCISCO, CA
Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,198,925,485
+$1,774,627,899 QoQ
Shares Held
6,001,955
+1.8% QoQ
Ownership
0.638%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#22
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $34,394,076,697 across 15 Drug Manufacturers - General names. LLY ranks #1 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
6,001,955 | $7,198,925,485 | |
| 2 | MRK |
Merck & Co., Inc.
|
54,365,289 | $6,985,939,635 | |
| 3 | AMGN |
Amgen Inc
|
15,034,038 | $5,444,125,839 | |
| 4 | JNJ |
Johnson & Johnson
|
19,126,165 | $4,857,472,124 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
67,595,177 | $3,894,834,098 | |
| 6 | ABBV |
AbbVie Inc.
|
12,914,230 | $3,249,736,836 | |
| 7 | PFE |
Pfizer Inc
|
52,548,228 | $1,265,361,329 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,155,281 | $1,030,338,200 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,198,925,485 | 6,001,955 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,424,297,586 | 5,897,450 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,188,229,399 | 5,758,206 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,297,514,333 | 5,632,391 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,178,010,303 | 5,359,653 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,334,002,368 | 5,247,548 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,887,084,848 | 5,035,084 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,283,714,806 | 4,835,220 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,368,472,986 | 4,825,016 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,636,387,309 | 4,674,260 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,658,437,554 | 4,560,553 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,382,338,597 | 4,435,311 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,038,794,409 | 4,347,295 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,481,508,385 | 4,313,984 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,566,577,000 | 4,282,137 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,360,463,113 | 4,207,401 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,244,031,602 | 3,836,880 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,108,043,995 | 3,869,274 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,045,762,014 | 3,785,975 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $859,066,773 | 3,718,099 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $841,339,299 | 3,665,647 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $669,944,179 | 3,586,041 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $605,980,604 | 3,589,082 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $529,805,025 | 3,579,280 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $638,503,900 | 3,889,048 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $527,047,635 | 3,799,363 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||